-
·
Significant Disparity: Myeloma Real-World Results Show Striking Contrast with Clinical Trials
Worse Outcomes for Myeloma Patients in Real-World Results vs. Clinical Trials Multiple myeloma patient outcomes are strikingly different in the real-world versus controlled environments according to data presented at the ASH Conference 2023 (Abstract 541). In the real world, multiple myeloma patients demonstrated a 44% reduction in progression-free survival (PFS) and a 75% decrease in…
